Scinopharm Taiwan Ltd. (1789)
TWSE
Closed
Aug 25, 2026
Day's Range
18.9552 wk Range
16.70Overview - 1789 - Scinopharm Taiwan Ltd.
Key Statistics
Valuation
Enterprise Value
14.42B
P/E (Trailing)
‪480.00‬
P/E (Forward)
‪48.00‬
PEG Ratio
‪48.00‬
Price / Sales (TTM)
‪4.94‬
Price / Book
‪1.63‬
EV / EBITDA
‪33.51‬
Profitability
Gross Margin
‪33.58%‬
Profit Margin
‪1.23%‬
Operating Margin
‪-9.64%‬
Return on Assets
‪-0.35%‬
Return on Equity
‪0.36%‬
Ownership
Shares Outstanding
790.73M
Float
277.71M
Held by Insiders
‪58.51%‬
Held by Institutions
‪15.27%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪19.84‬
200-Day Avg
‪20.31‬
Dividends
Payout Ratio
‪651.40%‬
Frequency
Annual
Peers - 1789 - Scinopharm Taiwan Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.
- 1789TWSEScinopharm Taiwan Ltd.14.94BMarket Cap+11.90%52-week change144.62P/E (Trailing)‪1.23%‬Profit Margin
- 1513TWSEChung-Hsin Electric & Machinery Manufacturing Corp.81.02BMarket Cap-2.13%52-week change18.43P/E (Trailing)‪15.73%‬Profit Margin
- 3030TWSETest Research Inc.66.49BMarket Cap+25.04%52-week change21.59P/E (Trailing)‪32.69%‬Profit Margin
- 1795TWSELotus Pharmaceutical Co., Ltd.49.40BMarket Cap-9.31%52-week change12.77P/E (Trailing)‪15.77%‬Profit Margin
- 4123TWSECenter Laboratories, Inc.26.06BMarket Cap-4.41%52-week change81.00P/E (Trailing)‪61.50%‬Profit Margin
- 4105TWSETTY Biopharm Company Limited19.14BMarket Cap+1.30%52-week change11.76P/E (Trailing)‪26.04%‬Profit Margin
- 4114TWSESynmosa Biopharma Corporation16.63BMarket Cap-7.31%52-week change19.21P/E (Trailing)‪12.38%‬Profit Margin
Profile Summary - 1789 - Scinopharm Taiwan Ltd.
About
Scinopharm Taiwan Ltd. operates as a specialized pharmaceutical company that focuses on the research, development, and manufacture of active pharmaceutical ingredients (APIs). Known for its strong emphasis on technological innovation and quality control, Scinopharm serves as a crucial entity in the global…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
